Indication
For treatment of symptomatic (New York Heart Association, NYHA, class II-III) obstructive hypertrophic cardiomyopathy (oHCM) in adult patients.
Medicine details
- Medicine name:
- aficamten (Myqorzo)
- SMC ID:
- SMC2958
- Pharmaceutical company
- Cytokinetics
- BNF chapter
- Cardiovascular system
- Submission type
- Abbreviated
- Publication due date:
- 07 December 2026